We are live on ! Find out more
BUB

BBVA USA Bancshares Portfolio holdings

AUM $2.1B
1-Year Est. Return 62.57%
This Fund
S&P 500
This Quarter Est. Return
-12.15%
1 Year Est. Return
+62.57%
3 Year Est. Return
+66.16%
5 Year Est. Return
+125.42%
10 Year Est. Return
AUM
$1.4B
AUM Growth
-$290M
Cap. Flow
-$70.9M
Cap. Flow %
-5.08%
Top 10 Hldgs %
23.76%
Holding
552
New
12
Increased
129
Reduced
345
Closed
41

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$8.73M
2
PX
Praxair Inc
PX
+$4.55M
3
ANDV
Andeavor
ANDV
+$3.24M
4
IWR icon
iShares Russell Mid-Cap ETF
IWR
+$2.69M
5
AMZN icon
Amazon
AMZN
+$2.43M

Sector Composition

Rank Sector Weight
1 Miscellaneous 32.92%
2 Financials 13.57%
3 Technology 10.41%
4 Healthcare 10.32%
5 Consumer Discretionary 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DE icon
51
Deere & Co
DE
$182B
$6.82M 0.49%
45,728
-1,529
-3% -$224K
BIV icon
52
Vanguard Intermediate-Term Bond ETF
BIV
$28.5B
$6.5M 0.47%
79,934
-9,042
-10% -$724K
UNH icon
53
UnitedHealth
UNH
$344B
$6.48M 0.46%
26,022
-233
-0.9% -$61.5K
TJX icon
54
TJX Companies
TJX
$139B
$6.3M 0.45%
140,747
-10,525
-7% -$532K
PM icon
55
Philip Morris
PM
$304B
$6.29M 0.45%
94,282
-7,288
-7% -$609K
CVS icon
56
CVS Health
CVS
$122B
$6.19M 0.44%
94,437
+49,265
+109% +$3.68M
XOM icon
57
ExxonMobil
XOM
$679B
$6.16M 0.44%
90,274
-6,100
-6% -$479K
NVO
58
Novo Nordisk
NVO
$192B
$5.92M 0.42%
257,226
-20,482
-7% -$455K
INTC icon
59
Intel
INTC
$514B
$5.9M 0.42%
125,767
-595
-0.5% -$27.9K
IEI icon
60
iShares 3-7 Year Treasury Bond ETF
IEI
$17.3B
$5.87M 0.42%
48,372
+38,637
+397% +$4.61M
REGN icon
61
Regeneron Pharmaceuticals
REGN
$81.7B
$5.84M 0.42%
15,627
-60
-0.4% -$22K
QCOM icon
62
Qualcomm
QCOM
$192B
$5.83M 0.42%
102,370
-7,171
-7% -$435K
MRK icon
63
Merck
MRK
$357B
$5.76M 0.41%
79,058
+4,671
+6% +$330K
IGSB icon
64
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
$5.6M 0.4%
108,485
-5,233
-5% -$270K
MET icon
65
MetLife
MET
$61.7B
$5.42M 0.39%
131,859
-13,114
-9% -$563K
DFS
66
DELISTED
Discover Financial Services
DFS
$5.41M 0.39%
91,800
-23,513
-20% -$1.62M
ACN icon
67
Accenture
ACN
$119B
$5.37M 0.38%
38,047
-107
-0.3% -$16.9K
LIN icon
68
Linde
LIN
$214B
$5.09M 0.36%
+32,627
New +$5.16M
VAR
69
DELISTED
Varian Medical Systems, Inc.
VAR
$5.08M 0.36%
44,806
-2,723
-6% -$311K
LOW icon
70
Lowe's Companies
LOW
$111B
$5.07M 0.36%
54,914
-276
-0.5% -$26.6K
MS icon
71
Morgan Stanley
MS
$324B
$5.06M 0.36%
127,591
-23,439
-16% -$1.02M
MRSH
72
Marsh
MRSH
$84.4B
$4.87M 0.35%
61,099
-3,001
-5% -$250K
MMM icon
73
3M
MMM
$83.6B
$4.87M 0.35%
30,575
-571
-2% -$94.8K
CVX icon
74
Chevron
CVX
$416B
$4.85M 0.35%
44,583
-343
-0.8% -$39.7K
YUM icon
75
Yum! Brands
YUM
$39.9B
$4.72M 0.34%
51,359
-1,742
-3% -$156K

Similar funds

BBVA USA Bancshares's Q4 2018 Portfolio in Review

As of Q4 2018, BBVA USA Bancshares held 552 positions worth $1.4B, down 17% from $1.69B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

BBVA USA Bancshares withdrew a net $70.9M in Q4 2018, closing 41 positions and reducing 345 holdings. Its most notable exit was Aetna Inc, an estimated $8.73M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 33% of assets, up from 31% a quarter earlier, followed by Financials and Technology.

Against the trend, BBVA USA Bancshares opened a new position in Linde worth $5.09M.

  • BBVA USA Bancshares's largest Q4 2018 buy was Linde: 32,627 shares worth $5.09M.
  • BBVA USA Bancshares added most to State Street SPDR S&P Dividend ETF in Q4 2018, an estimated $8.5M increase.
  • BBVA USA Bancshares's biggest Q4 2018 reduction was iShares Russell Mid-Cap ETF, cutting an estimated $2.69M.
  • BBVA USA Bancshares fully exited Aetna Inc in Q4 2018, selling an estimated $8.73M.
  • BBVA USA Bancshares's ten largest holdings make up 24% of its $1.4B portfolio in Q4 2018.
  • BBVA USA Bancshares opened 12 new positions and closed 41 in Q4 2018.
  • BBVA USA Bancshares's portfolio value fell 17% quarter-over-quarter to $1.4B.

Based on BBVA USA Bancshares's 13F filing for Q4 2018, filed 8 Feb 2019.